Squarepoint’s ARS Pharmaceuticals SPRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-76,824
| Closed | -$966K | – | 3166 |
|
|
2025
Q1 | $966K | Buy |
76,824
+52,047
| +210% | +$655K | ﹤0.01% | 1535 |
|
|
2024
Q4 | $261K | Sell |
24,777
-9,204
| -27% | -$97.1K | ﹤0.01% | 2259 |
|
|
2024
Q3 | $493K | Buy |
+33,981
| New | +$493K | ﹤0.01% | 1763 |
|
|
2023
Q3 | – | Sell |
-84,808
| Closed | -$568K | – | 2832 |
|
|
2023
Q2 | $568K | Buy |
84,808
+71,905
| +557% | +$482K | ﹤0.01% | 1540 |
|
|
2023
Q1 | $84K | Buy |
+12,903
| New | +$84K | ﹤0.01% | 2055 |
|
|
2021
Q4 | – | Sell |
-15,593
| Closed | -$156K | – | 2796 |
|
|
2021
Q3 | $156K | Buy |
15,593
+6,492
| +71% | +$64.9K | ﹤0.01% | 1918 |
|
|
2021
Q2 | $281K | Buy |
+9,101
| New | +$281K | ﹤0.01% | 2015 |
|